Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 16:9:996442.
doi: 10.3389/fmed.2022.996442. eCollection 2022.

Nocardiosis: A two-center analysis of clinical characteristics

Affiliations

Nocardiosis: A two-center analysis of clinical characteristics

Lumin Wang et al. Front Med (Lausanne). .

Erratum in

Abstract

Objective: The objective of the present study was to describe and analyze the clinical characteristics of nocardiosis.

Materials and methods: We described and analyzed the clinical characteristics of nocardiosis cases from two centers over the past 5 years from the following aspects: age and sex, Nocardia species, sites of Nocardia infection, test specimens, detection methods, concurrent pathogens, symptoms, imaging features, co-conditions, drug susceptibility tests, antibiotic therapy/duration, outcomes, and follow-up.

Results: The median age of the 19 cases was 64 years, with an interquartile range (IQR) of 56-68 years. Eight cases (42.1%) were immunocompromised [those who had been on corticosteroid use (62.5%), those who had used immunosuppressants (50.0%), or those who had suffered from chronic nephrosis (37.5%) or diabetes mellitus (DM) (25.0%)]. The plethora of comorbidities of these cases included diabetes (10.5%), chronic kidney disease (CDK) (15.8%), chronic lung disease (36.8%), and rheumatic diseases (10.5%). Cough and expectoration (73.7%) was the most common symptom of nocardiosis. The respiratory tract (89.5%) was the most common site of the clinical disease. Nearly half (9 cases, 47.3%) of these patients had concurrent infections. The most common Nocardia isolation site was the respiratory tract (73.7%). All patients were given antibiotic therapies, out of whom as many as 63.6% of patients were treated with two concurrent antimicrobial agents, 15.8% of patients were treated under monotherapy and 21.1% of patients were treated with three or more concurrent antimicrobial agents.

Conclusions: An uncommon life-threatening infection, nocardiosis, affects those patients with structural lung disease or immunosuppression. Although nocardiosis is capable of progressing into a serious and metastatic disease, early recognition and prompt treatment usually result in successful outcomes benefitting the patient.

Keywords: Nocardia; clinical characteristics; immunosuppressed; nocardiosis; two-center retrospective study.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Spine and joint MRI (Case 10 and Case 18X). (A) Case 10, spinal magnetic resonance imaging (MRI), abnormal signals in the L3 and L4 vertebrae, abscess, narrowing intervertebral space and disappearance of the normal disc signal. (B) Case 18X, left wrist joint MRI, left distal ulna, multiple carpal and metacarpal bone destruction, left wrist joint soft tissue swelling.
Figure 2
Figure 2
Comparison of chest computed tomography (CT) before and after treatment (Case 16X and Case 17X). (A,B) Comparison of chest computed tomography (CT) before and after 4 weeks of antibiotic treatment (Case 16X). (A) Plain chest CT scan before antibiotic therapy. (B) Plain chest CT scan after 1 month of antibiotic therapy. (C,D) Comparison of chest CT before and after 3 months of antibiotic treatment (Case 17X). (C) Plain chest CT scan before antibiotic therapy. The red box is a typical Nocardia infection site. (D) Plain chest CT scan after 3 months of antibiotic therapy. Inflammation of the red box had subsided.

References

    1. Wilson JW. Nocardiosis: updates and clinical overview. Mayo Clin Proc. (2012) 87:403–7. 10.1016/j.mayocp.2011.11.016 - DOI - PMC - PubMed
    1. Beaman BL. Nocardia species-host-parasite relationships. Clin Microbiol Rev. (1994) 7:213–64. 10.1128/CMR.7.2.213 - DOI - PMC - PubMed
    1. Kontoyiannis DP, Ruoff K, Hooper DC. Nocardia bacteremia. Report of 4 cases and review of the literature. Medicine. (1998) 77:255–67. 10.1097/00005792-199807000-00004 - DOI - PubMed
    1. Budzik JM, Hosseini M, Mackinnon Jr AC, Taxy JB. Disseminated Nocardia farcinica: literature review and fatal outcome in an immunocompetent patient. Surg Infect (Larchmt). (2012) 13:163–70. 10.1089/sur.2011.012 - DOI - PMC - PubMed
    1. Brown-Elliott BA, Brown JM, Conville PS, Wallace RJ, Jr. Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy. Clin Microbiol Rev. (2006) 19:259–82. 10.1128/CMR.19.2.259-282.2006 - DOI - PMC - PubMed